Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

Amalgamation of complex iron(III) ions and iron nanoclusters with MWCNTs as a route to potential T2 MRI contrast agents

Authors Kuźnik N, Tomczyk M, Wyskocka M, Przypis, Herman A, Jędrysiak R, Koziol K, Boncel S

Received 22 January 2015

Accepted for publication 2 March 2015

Published 14 May 2015 Volume 2015:10(1) Pages 3581—3591


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Thomas J Webster

Nikodem Kuźnik,1 Mateusz M Tomczyk,1 Marzena Wyskocka,1 Łukasz Przypis,1 Artur P Herman,1 Rafał Jędrysiak,1 Krzysztof K Koziol,2 Slawomir Boncel1

1Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty of Chemistry, Silesian University of Technology, Gliwice, Poland; 2Department of Materials Science and Metallurgy, University of Cambridge, Cambridge, UK

Abstract: Iron-filled multiwall carbon nanotubes (Fe@MWCNTs) were functionalized toward a variety of potential magnetic resonance imaging contrast agents. Oxidized Fe@MWNCTs were covered with PEG5000 via direct esterification or using acyl chloride derivatives. Alternatively, the latter were functionalized with an aminophenol ligand (Fe@O-MWCNT-L). Moreover, pristine Fe@MWCNTs were functionalized with N-phenylaziridine groups (Fe@f-MWCNT) via [2+1] cycloaddition of nitrene. All of these chemically modified nanotubes served as a vehicle for anchoring Fe3+ ions. The new hybrids – Fe(III)/Fe@(f-/O-)MWCNTs – containing 6%–14% of the “tethered” Fe3+ ions were studied in terms of the acceleration of relaxation of water protons in nuclear magnetic resonance. The highest transverse relaxivity r2=63.9±0.9 mL mg-1 s-1 was recorded for Fe(III)/Fe@O-MWCNT-L, while for Fe(III)/Fe@f-MWCNT, with r2=57.9±2.9 mL mg-1 s-1, the highest impact of the anchored Fe(III) ions was observed. The T1/T2 ratio of 30–100 found for all of the nanotube hybrids presented in this work is a very important factor for their potential application as T2 contrast agents. Increased stability of the hybrids was confirmed by ultraviolet–visible spectrophotometry.

Keywords: multiwall carbon nanotubes, Fe3+, transverse relaxation time T2, MRI contrast agent

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model

Boechat AL, Oliveira CP, Tarragô AM, Costa AG, Malheiro A, Guterres SS, Pohlmann AR

International Journal of Nanomedicine 2015, 10:6603-6614

Published Date: 22 October 2015

Potential toxicity of dental nanomaterials to the central nervous system

Solla DF, Paiva TS, André M, Paiva WS

International Journal of Nanomedicine 2015, 10:5593-5596

Published Date: 3 September 2015

Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cells

Tran TH, Ramasamy T, Choi JY, Nguyen HT, Pham TT, Jeong JH, Ku SK, Choi HG, Yong CS, Kim JO

International Journal of Nanomedicine 2015, 10:5249-5262

Published Date: 21 August 2015

MRI-detectable polymeric micelles incorporating platinum anticancer drugs enhance survival in an advanced hepatocellular carcinoma model

Vinh NQ, Naka S, Cabral H, Murayama H, Kaida S, Kataoka K, Morikawa S, Tani T

International Journal of Nanomedicine 2015, 10:4137-4147

Published Date: 25 June 2015

Enzyme-responsive nanocomposites for wound infection prophylaxis in burn management: in vitro evaluation of their compatibility with healing processes

Grützner V, Unger RE, Baier G, Choritz L, Freese C, Böse T, Landfester K, Kirkpatrick CJ

International Journal of Nanomedicine 2015, 10:4111-4124

Published Date: 24 June 2015

Upconversion nanoparticle-mediated photodynamic therapy induces THP-1 macrophage apoptosis via ROS bursts and activation of the mitochondrial caspase pathway

Zhu X, Wang H, Zheng LB, Zhong ZY, Li XS, Zhao J, Kou JY, Jiang YQ, Zheng XF, Liu ZN, Li HX, Cao WW, Tian Y, Wang Y, Yang LM

International Journal of Nanomedicine 2015, 10:3719-3736

Published Date: 22 May 2015

pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin

Sun S, Liang N, Yamamoto H, Kawashima Y, Cui F, Yan P

International Journal of Nanomedicine 2015, 10:3489-3498

Published Date: 11 May 2015

Effects of PVA coated nanoparticles on human immune cells

Strehl C, Gaber T, Maurizi L, Hahne M, Rauch R, Hoff P, Häupl T, Hofmann-Amtenbrink M, Poole AR, Hofmann H, Buttgereit F

International Journal of Nanomedicine 2015, 10:3429-3445

Published Date: 8 May 2015

A hybrid substratum for primary hepatocyte culture that enhances hepatic functionality with low serum dependency

Meng QY, Tao CS, Qiu ZY, Akaike T, Cui FZ, Wang XM

International Journal of Nanomedicine 2015, 10:2313-2323

Published Date: 23 March 2015